Tata India Pharma & Healthcare Fund Regular-Growth
Equity
Sectoral-Pharma
₹0.83% 1D
NAV on
Overview
Chart
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Overview
Rating
2
Minimum Investment
₹5000
NAV (Net Asset Value)
₹N/A
AUM (Fund size)
₹1566 Cr
Created on
1 Dec 2015
Fund Ranking
#16
/ 17 in Sectoral-Pharma
Risk Level
Very High
Very High
Loading...
Returns
Trailing Return
Rolling Return
6 Month
14.4%
1 Year
5.4%
3 Year (CAGR)
17.1%
All Time (CAGR)
11.4%
Category Return
6 Month
19.1%
1 Year
13.8%
3 Year (CAGR)
20.2%
All Time (CAGR)
17.0%
Asset Allocation
Equity
99.5%
Other
0.5%
Top 5 Holdings
Top 5 Sectors
Apollo Hospitals Enterprise
4.32%
Bayer CropScience
3.01%
Cipla
4.27%
Dr. Reddy's Laboratories
4.21%
FDC
2.10%
Fund Information
Expense Ratio
2.41%
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Lock-In Period
No Lock-In
Managed By
Meeta Shetty
Nov 2018 - Present
Rajat Srivastava
Sep 2024 - Present
Risk & Return Ratio
Sharpe Ratio
Sharpe Ratio evaluates a fund's return relative to its risk. Higher values signify better risk-adjusted performance.
0.68
Standard Deviation
Standard deviation measures the volatility of a fund's returns. The higher the value, the riskier the investment.
16.71
Alpha
Alpha in mutual funds measures excess return relative to a benchmark, indicating a manager's skill at generating returns beyond market performance.
-3.72
Beta
Beta in mutual funds indicates a fund's sensitivity to market changes. A beta over 1 means it's more volatile than the market, while below 1 implies less volatility.